Cargando…

The Therapeutic Efficacy of Danhong Injection Combined With Percutaneous Coronary Intervention in Acute Coronary Syndrome: A Systematic Review and Meta-Analysis

Background: Percutaneous coronary intervention (PCI) is widely used in treatment of acute coronary syndrome (ACS) clinically. It is believed that Danhong injection (DHI) extracted from salviae miltiorrhizae and flos carthami combined with PCI could increase the therapeutic efficacy on ACS. We provid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zou, Jun-Bo, Zhang, Xiao-Fei, Wang, Jing, Wang, Fang, Cheng, Jiang-Xue, Yang, Fang-Yan, Song, Xiao, Wang, Yu, Liang, Yu-Lin, Shi, Ya-Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5994407/ https://www.ncbi.nlm.nih.gov/pubmed/29915535 http://dx.doi.org/10.3389/fphar.2018.00550

Ejemplares similares

Danhong Injection Protects Hemorrhagic Brain by Increasing Peroxiredoxin 1 in Aged Rats
por: Wang, Shang, et al.
Publicado: (2020)

Danhong Injection Price Trend and Its Utilization by Coronary Heart Disease Patients: Evidence From Hospital Records in China
por: Liu, Liming, et al.
Publicado: (2022)

Danhong Injection for the Treatment of Hypertensive Nephropathy: A Systematic Review and Meta-Analysis
por: Li, YiZhuo, et al.
Publicado: (2020)

Danhong Injection Attenuates Cerebral Ischemia-Reperfusion Injury in Rats Through the Suppression of the Neuroinflammation
por: Du, Haixia, et al.
Publicado: (2021)

Pharmacological Mechanisms Underlying the Therapeutic Effects of Danhong Injection on Cerebral Ischemia
por: Qi, Yifei, et al.
Publicado: (2021)

Protective effect of Danhong injection in patients with acute myocardial infarction at a high risk of no-reflow during primary percutaneous coronary intervention
por: You, Qi, et al.
Publicado: (2019)

Effect of Danhong injection on prognosis and inflammatory factor expression in patients with acute coronary syndrome during the perioperative period of percutaneous coronary intervention: A systematic review and meta-analysis
por: Li, Yuxuan, et al.
Publicado: (2022)

Danhong Injection Combined With t-PA Improves Thrombolytic Therapy in Focal Embolic Stroke
por: Li, Min, et al.
Publicado: (2018)

Comparison of the Efficacy of Danhong Injections at Different Time-points During the Perioperative Period of Acute Myocardial Infarction: A Systematic Review and Meta-analysis of Randomized Controlled Trials
por: He, Qing-Ying, et al.
Publicado: (2021)

Efficacy and safety of Danhong injection on endothelial function and inflammatory factors after the percutaneous coronary intervention for coronary heart disease: A protocol of systematic review and meta-analysis of randomized controlled trials
por: Li, Shujuan, et al.
Publicado: (2020)

Danhong Injection Reversed Cardiac Abnormality in Brain–Heart Syndrome via Local and Remote β-Adrenergic Receptor Signaling
por: Orgah, John O., et al.
Publicado: (2018)

The add-on effects of Danhong injection among patients with ischemic stroke receiving Western medicines: A systematic review and meta-analysis
por: Ma, Yu, et al.
Publicado: (2022)

Neuroprotective Effect of Danhong Injection on Cerebral Ischemia-Reperfusion Injury in Rats by Activation of the PI3K-Akt Pathway
por: Feng, Chen, et al.
Publicado: (2020)

Postmarketing Safety Surveillance and Reevaluation of Danhong Injection: Clinical Study of 30888 Cases
por: Li, Xue-Lin, et al.
Publicado: (2015)

Danhong injection attenuates doxorubicin-induced cardiotoxicity in rats via suppression of apoptosis: network pharmacology analysis and experimental validation
por: Yi, Xiaojiao, et al.
Publicado: (2022)

Effects of sodium tanshinone IIA sulfonate injection on inflammatory factors and vascular endothelial function in patients with acute coronary syndrome undergoing percutaneous coronary intervention: A systematic review and meta-analysis of randomized clinical trials
por: Kan, Zunqi, et al.
Publicado: (2023)

Impact of CYP2C19 Variants on Clinical Efficacy of Clopidogrel and 1-Year Clinical Outcomes in Coronary Heart Patients Undergoing Percutaneous Coronary Intervention
por: Sun, Hong, et al.
Publicado: (2016)

The Management of Heavy Menstrual Bleeding After Percutaneous Coronary Intervention in a Woman of Reproductive Age
por: Gu, Zhi-Chun, et al.
Publicado: (2019)

Specific Combination of Salvianolic Acids As Core Active Ingredients of Danhong Injection for Treatment of Arterial Thrombosis and Its Derived Dry Gangrene
por: Zhao, Tiechan, et al.
Publicado: (2017)

Transcriptomic Study Reveals Recovery of Impaired Astrocytes Contribute to Neuroprotective Effects of Danhong Injection Against Cerebral Ischemia/Reperfusion-Induced Injury
por: Qian, Jing, et al.
Publicado: (2018)

Effect of indobufen vs. aspirin on platelet accumulation in patients with stable coronary heart disease after percutaneous coronary intervention: An open-label crossover study
por: Shi, Qiu-Ping, et al.
Publicado: (2022)

Characteristic and Mechanism of Drug-Herb Interaction Between Acetylsalicylic Acid and Danhong Injection Mediated by Organic Anion Transporters
por: Li, Jianping, et al.
Publicado: (2020)

Incident Heart Failure in Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
por: Gu, Jun, et al.
Publicado: (2021)

Revealing Calcium Signaling Pathway as Novel Mechanism of Danhong Injection for Treating Acute Myocardial Infarction by Systems Pharmacology and Experiment Validation
por: Guo, Siyu, et al.
Publicado: (2022)

Network pharmacology exploration reveals endothelial inflammation as a common mechanism for stroke and coronary artery disease treatment of Danhong injection
por: Lyu, Ming, et al.
Publicado: (2017)

Detection of an anti-angina therapeutic module in the effective population treated by a multi-target drug Danhong injection: a randomized trial
por: Liu, Jun, et al.
Publicado: (2021)

Protective Effects of Danhong Injection against Cerebral Damage during On-Pump Coronary Artery Bypass Graft Surgery
por: Xuejuan, Zhang, et al.
Publicado: (2015)

Initiate Danhong Injection before or after percutaneous coronary intervention for microvascular obstruction in ST-elevation myocardial infarction (DIRECTION): study protocol for a randomized controlled trial
por: Zhang, Xiaoyu, et al.
Publicado: (2020)

Musk Tongxin Dripping Pills for treating Ticagrelor in Patients After Percutaneous Coronary Intervention: Echocardiography Combined with Untargeted Metabolomics
por: Nan, Lyu, et al.
Publicado: (2021)

An Overview of Meta-Analyses of Danhong Injection for Unstable Angina
por: Zhang, Xiaoxia, et al.
Publicado: (2015)

Danhong Injection Enhances the Therapeutic Efficacy of Mesenchymal Stem Cells in Myocardial Infarction by Promoting Angiogenesis
por: Chen, Jingrui, et al.
Publicado: (2018)

Comparative efficacy and safety of antiplatelet or anticoagulant therapy in patients with chronic coronary syndromes after percutaneous coronary intervention: A network meta-analysis of randomized controlled trials
por: Lin, Yaowang, et al.
Publicado: (2022)

An Overview of Systematic Reviews of Danhong Injection for Ischemic Stroke
por: Wang, Hui, et al.
Publicado: (2016)

Health-promoting Lifestyle in Patients after Percutaneous Coronary Intervention
por: Xiao, Ling, et al.
Publicado: (2018)

Danhong injection in the treatment of chronic stable angina: study protocol for a randomized controlled trial
por: Wang, Peng Qian, et al.
Publicado: (2015)

A Simple Clinical Pre-procedure Risk Model for Predicting Thrombocytopenia Associated With Periprocedural Use of Tirofiban in Patients Undergoing Percutaneous Coronary Intervention
por: Yi, Yi-Hu, et al.
Publicado: (2018)

A Defined Combination of Four Active Principles From the Danhong Injection Is Necessary and Sufficient to Accelerate EPC-Mediated Vascular Repair and Local Angiogenesis
por: He, Shuang, et al.
Publicado: (2019)

Serum Homocysteine Level Predictive Capability for Severity of Restenosis Post Percutaneous Coronary Intervention
por: Guo, Jiqiang, et al.
Publicado: (2022)

Association of ABCC2 polymorphism with clopidogrel response in Chinese patients undergoing percutaneous coronary intervention
por: Chen, Lida, et al.
Publicado: (2022)

Percutaneous Management of Iatrogenic Aortocoronary Dissection Complicating Diagnostic Angiography or Percutaneous Coronary Intervention
por: Tang, Liang, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_kdn6adfp05bgimmt8ftc7gkose